NCT05542524View on ClinicalTrials.gov

Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

August 31, 2023

Conditions

Giant Cell Tumors

Trial Locations (1)

67091

Service de Médecine et Chirurgie Bucco-Dentaires - CHU de Strasbourg - France, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER